PSMD14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.934200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.149800E-01
Normal-vs-Stage2
2.875000E-01
Normal-vs-Stage3
6.012800E-01
Normal-vs-Stage4
4.613200E-01
Stage1-vs-Stage2
4.460400E-01
Stage1-vs-Stage3
8.543600E-01
Stage1-vs-Stage4
7.812200E-01
Stage2-vs-Stage3
7.067000E-01
Stage2-vs-Stage4
7.623600E-01
Stage3-vs-Stage4
9.602000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.057600E-01
Normal-vs-AfricanAmerican
2.011400E-01
Normal-vs-Asian
3.544000E-01
Caucasian-vs-AfricanAmerican
5.649600E-01
Caucasian-vs-Asian
6.286800E-01
AfricanAmerican-vs-Asian
8.881600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.222400E-01
Normal-vs-Female
2.598800E-01
Male-vs-Female
1.596830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.824000E-01
Normal-vs-Age(41-60Yrs)
1.050560E-01
Normal-vs-Age(61-80Yrs)
4.104800E-01
Normal-vs-Age(81-100Yrs)
2.010400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.011800E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.183600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.146100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.056000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.789590E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.608400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.687400E-01
Normal-vs-Daily Drinker
5.321200E-01
Normal-vs-Weekly Drinker
4.460800E-01
Normal-vs-Occasional Drinker
7.309700E-02
Normal-vs-Social Drinker
1.610400E-01
Non Drinker-vs-Daily Drinker
9.855600E-01
Non Drinker-vs-Weekly Drinker
3.460000E-01
Non Drinker-vs-Occasional Drinker
1.015680E-02
Non Drinker-vs-Social Drinker
5.125200E-01
Daily Drinker-vs-Weekly Drinker
3.526800E-01
Daily Drinker-vs-Occasional Drinker
1.189740E-02
Daily Drinker-vs-Social Drinker
5.394000E-01
Weekly Drinker-vs-Occasional Drinker
5.773000E-01
Weekly Drinker-vs-Social Drinker
4.951000E-01
Occasional Drinker-vs-Social Drinker
2.383800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.644800E-01
Normal-vs-Grade 2
8.145400E-01
Normal-vs-Grade 3
8.165400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.185700E-02
Grade 1-vs-Grade 3
3.180000E-02
Grade 1-vs-Grade 4
9.644800E-01
Grade 2-vs-Grade 3
9.725800E-01
Grade 2-vs-Grade 4
8.145400E-01
Grade 3-vs-Grade 4
8.165400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.978200E-01
Normal-vs-NonDiabetic
2.809400E-01
Diabetic-vs-NonDiabetic
7.892000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.114600E-01
Normal-vs-NoPancreatitis
3.332600E-01
Pancreatitis-vs-NoPancreatitis
8.785800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.957770E-01
Normal-vs-N1
2.974400E-01
N0-vs-N1
3.157600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.206200E-02
Normal-vs-TP53-NonMutant
7.514400E-01
TP53-Mutant-vs-TP53-NonMutant
5.58379997794844E-09
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
